Sustanon 250 by Aspen is a pharmaceutical-grade testosterone blend containing four testosterone esters — propionate, phenylpropionate, isocaproate, and decanoate — formulated to deliver a multi-phase release profile of exogenous testosterone. The combination of short- and long-acting esters is a subject of clinical interest for its association with sustained serum androgen concentrations following a single intramuscular administration.
✔ Key Research Insights
- Studied for its multi-phase pharmacokinetic profile, with each ester contributing a distinct absorption and release curve in research subjects
- Investigated for its effects on muscle protein synthesis and nitrogen retention in documented androgen research
- Researched for its influence on lean mass preservation and metabolic parameters across varied caloric protocols in clinical observations
- Examined for its capacity to maintain stable serum testosterone concentrations, minimizing hormonal fluctuation relative to single-ester formulations
- Documented for its balanced anabolic-to-androgenic ratio across comparative androgen research literature
📦 Product Specifications
- Manufacturer: Aspen
- Form: Injectable solution (1 ml ampoule)
- Molecule: Testosterone Blend (Sustanon 250)
- Concentration: 250 mg/ml
- Composition:
- Testosterone Propionate: 30 mg
- Testosterone Phenylpropionate: 60 mg
- Testosterone Isocaproate: 60 mg
- Testosterone Decanoate: 100 mg
- Dosage considerations may vary. Consulting a qualified professional is recommended.
⚙ How It Works
Sustanon 250 delivers four testosterone esters simultaneously via intramuscular injection. In research subjects, each constituent ester undergoes hydrolysis at a distinct rate, releasing free testosterone into systemic circulation across an extended time window. Testosterone propionate contributes to early androgen availability, while phenylpropionate, isocaproate, and decanoate provide progressively sustained release phases. This staggered absorption mechanism is associated with reduced serum fluctuation compared to single-ester testosterone preparations. As with all aromatizable androgens, conversion to estrogen via the aromatase enzyme has been documented in clinical observations, with estrogenic effects including fluid retention and gynecomastia noted as potential sequelae in susceptible subjects. Co-administration of aromatase inhibitors or selective estrogen receptor modulators is referenced in clinical literature as a management strategy for estrogen-related effects.
⭐ Product Overview
- Manufactured by Aspen to pharmaceutical-grade purity and potency standards
- Precisely composed four-ester testosterone blend with documented pharmacokinetic advantages over single-ester formulations
- Established compound with extensive clinical and endocrinological research history
- Widely referenced in international androgen therapy literature under the Sustanon 250 designation
- Consistent ampoule formulation ensuring accurate dosing per administration
Sustanon 250 (1ml ampoule )
Sustanon 250 is typically injected every 7 to 10 days to maintain stable testosterone levels in the body. This schedule allows for consistent hormone release and helps to minimize fluctuations in testosterone levels, which is particularly important for maximizing the benefits of the steroid while minimizing side effects. Some users may choose to inject it more frequently (e.g., twice a week) for even steadier levels, but this depends on personal preference and tolerance.






















